Literature DB >> 15977101

Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

Y Mori1, K Hoshino, K Yokota, T Yokose, N Tajima.   

Abstract

BACKGROUND: Impaired glucose tolerance (IGT) represents a stage of pre-diabetes and is a risk factor for future cardiovascular disease (CVD) which is a major cause of death in type 2 diabetes. The metabolic risk factors such as elevated blood pressure (elevated BP), abdominal obesity, dyslipidemia (elevated levels of total triglycerides [TG] and low levels of HDL cholesterol), and hyperglycemia precede the onset of the metabolic syndrome that increases the risk for CVD. This clustering is commonly associated with pre-diabetic hyperinsulinemia and it reflects peripheral insulin resistance. The present study documented that a visceral fat area (VFA) >/= 100 cm (2) can replace waist-to-hip ratios (WHR) associated with IGT or IFG/IGT as a critical risk for the development of the metabolic syndrome in Japanese middle-aged men.
MATERIALS AND METHODS: A total of 575 middle-aged Japanese men with fasting plasma glucose levels of 6.1 - 6.9 mmol/l (impaired fasting glucose; IFG) were enrolled in the study. After a 75-g oral glucose tolerance test (OGTT), blood samples were collected 0 - 2 h later for determination of plasma glucose, insulin concentrations and other variables. Based on the results of an OGTT, the subjects were subgrouped into categories of glucose tolerance for further study.
RESULTS: Subjects with IGT or IFG/IGT had significantly higher levels of metabolic abnormalities such as high BMI, increased AUC glucose, elevated HbA1c, high VFA, elevated BP, and increased TG levels when compared to NGT (normal glucose tolerance) (p < 0.001). Compensatory hyper-secretion of insulin was seen in all pre-diabetic subjects, and was higher in IFG/IGT subjects (681 +/- 33 pmol . h/l) than NGT (480 +/- 22 pmol . h/l) (p < 0.01). The metabolic clustering including abnormal VFA, TG, HDL-C, and BP was strongly associated with the development of metabolic syndrome. Interestingly, VFA >/= 100 cm (2) adjusted for the Japanese correlates strongly with the development of the metabolic syndrome in preclinical IGT or IFG/IGT subjects, with odds ratios of 2.7 and higher.
CONCLUSION: VFA >/= 100 cm (2) strongly correlates with prediabetic IGT or IFG/IGT which is possibly associated with underlying insulin resistance, and is a critical risk factor linked to the development of metabolic syndrome in Japanese middle-aged subjects with IGT or IFG/IGT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15977101     DOI: 10.1055/s-2005-865680

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  10 in total

1.  Japanese IGT subjects with high insulin response are far more frequently associated with the metabolic syndrome than those with low insulin response.

Authors:  Yutaka Mori; Kyouko Hoshino; Kuninobu Yokota; Yohta Itoh; Naoko Tajima
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  The effects of resistance training on muscle and body fat mass and muscle strength in type 2 diabetic women.

Authors:  Hwi Ryun Kwon; Kyung Ah Han; Yun Hyi Ku; Hee Jung Ahn; Bo-Kyung Koo; Ho Chul Kim; Kyung Wan Min
Journal:  Korean Diabetes J       Date:  2010-04-30

3.  Worksite health screening programs for predicting the development of Metabolic Syndrome in middle-aged employees: a five-year follow-up study.

Authors:  Yu-Cheng Lin; Jong-Dar Chen; Su-Huey Lo; Pau-Chung Chen
Journal:  BMC Public Health       Date:  2010-12-02       Impact factor: 3.295

4.  Effect of longitudinal changes in visceral fat area and other anthropometric indices to the changes in metabolic risk factors in Japanese men: the Hitachi Health Study.

Authors:  Yumi Matsushita; Toru Nakagawa; Shuichiro Yamamoto; Yoshihiko Takahashi; Tetsuji Yokoyama; Tetsuya Mizoue; Mitsuhiko Noda
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

5.  Abdominal Obesity and Association With Atherosclerosis Risk Factors: The Uberlândia Heart Study.

Authors:  Leonardo S Roever; Elmiro S Resende; Angélica L D Diniz; Nilson Penha-Silva; Fernando C Veloso; Antonio Casella-Filho; Paulo M M Dourado; Antonio C P Chagas
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

6.  Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo.

Authors:  Konstanze Zieger; Juliane Weiner; Anne Kunath; Martin Gericke; Kerstin Krause; Matthias Kern; Michael Stumvoll; Nora Klöting; Matthias Blüher; John T Heiker
Journal:  Cell Mol Life Sci       Date:  2017-09-20       Impact factor: 9.261

7.  Usefulness of waist-to-height ratio in screening incident metabolic syndrome among Japanese community-dwelling elderly individuals.

Authors:  Ryuichi Kawamoto; Asuka Kikuchi; Taichi Akase; Daisuke Ninomiya; Teru Kumagi
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

8.  The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity.

Authors:  Naohiko Ueno
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-01-22

9.  Visceral fat area is associated with HbA1c but not dialysate-related glucose load in nondiabetic PD patients.

Authors:  Li-chun Ho; Chung-Jen Yen; Chia-Ter Chao; Chih-Kang Chiang; Jenq-Wen Huang; Kuan-Yu Hung
Journal:  Sci Rep       Date:  2015-08-04       Impact factor: 4.379

10.  Zuo Gui Wan Alters Expression of Energy Metabolism Genes and Prevents Cell Death in High-Glucose Loaded Mouse Embryos.

Authors:  Qi Liang; Zhipeng Qu; Yu Liang; QianJin Feng; Xin Niu; Temaka Bai; Yingli Wang; Qiang Song; David L Adelson
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-25       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.